bluebird bio, Inc. Patent Applications Rejected
2 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-09-27: Application 17598637; Invention BETA-THALASSEMIA POTENCY ASSAY; Applicant bluebird bio, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2021-09-17: Application 17440543; Invention SICKLE CELL POTENCY ASSAY; Applicant bluebird bio, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2021-09-27 | 17598637 | BETA-THALASSEMIA POTENCY ASSAY | bluebird bio, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220163512A1 | ILYA SHESTOPALOV MELISSA BONNER | United States United States | TRAN, KHOA NHAT |
| 2021-09-17 | 17440543 | SICKLE CELL POTENCY ASSAY | bluebird bio, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220154145A1 | ILYA SHESTOPALOV MELISSA BONNER GRETCHEN AMBERLEA MAI LEWIS | United States United States United States | ROGERS, ERIC JASON |